# Excel Industries share price today (Excel Industries Ltd, NSE: EXCELINDUS)

> Excel Industries share price today: ₹875.40 at the NSE close on 4 November 2026, down 20.0% in a year. Excel Industries (NSE: EXCELINDUS) is worth ₹1,101 crore, trades at a P/E of 15.4 and has closed between ₹836.75 and ₹1,093.90 over the past 52 weeks. > Excel Industries Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. EXCELINDUS · Pesticides/Agrochemicals · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/excel-industries-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹875.40 (−20.0% in a year)
- P/E: 15.4× (lower than 61% of the last 11 years)
- Revenue (Jun 2026): ₹294 Cr (−5.2% on a year ago)
- Profit (Jun 2026): ₹29.0 Cr (−14.7% on a year ago)
- Operating margin: 14.0% (flat on a year ago)
- ROCE: 6%, FY26
- ROIC: 3.6%, against a 12.0% cost of capital: −8.4 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Excel Industries share price today? Excel Industries Ltd's share price was ₹875.40 at the close on 4 November 2026. It has been falling for 2 weeks. That is 9.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹837 and ₹1,094, and at that close it sat 15% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 3 weeks running. Over the last 11 years the share price moved +292% while the NIFTY 500 moved +243%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Excel Industries this quarter? Two changes stood out: revenue fell in the June 2026 quarter and foreign funds (FIIs) cut their stake for 3 quarters in a row. 1. Revenue fell in the June 2026 quarter Revenue was ₹294 crore, -5.2% on a year earlier (₹310 crore), after 9 quarters of growth. 2. Foreign funds (FIIs) cut their stake for 3 quarters in a row From 2% to 1.7% of the company by the September 2026 quarter. ## What are Excel Industries' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Excel Industries reported revenue of ₹294 crore, down 5.2% from ₹310 crore a year earlier, and a profit of ₹29.0 crore, down 14.7% from ₹34.0 crore. ### Excel Industries results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹294 crore | ₹310 crore | −5.2% |
| Profit | ₹29.0 crore | ₹34.0 crore | −14.7% |
| Earnings per share | ₹23.44 | ₹26.86 | −12.7% |
| Operating margin | 14.0% | 14.0% | 0.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 25 May 2026, about January to March 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Excel Industries share price history? Excel Industries closed at ₹875.40 on 4 November 2026, down 20.0% from ₹1,093.90 a year earlier (7 November 2025) and down 9.7% over five years. Its highest weekly close since April 2016 was ₹1,813.65 on 14 September 2018. ### Excel Industries share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹846.20 | +3.5% |
| 1 month ago · 1 Oct 2026 | ₹921.75 | −5.0% |
| 6 months ago · 8 May 2026 | ₹1,024.55 | −14.6% |
| 1 year ago · 7 Nov 2025 | ₹1,093.90 | −20.0% |
| 3 years ago · 3 Nov 2023 | ₹864.05 | +1.3% |
| 5 years ago · 4 Nov 2021 | ₹969.05 | −9.7% |
| 10 years ago · 4 Nov 2016 | ₹435.20 | +101.1% |
| Earliest and lowest weekly close in our records · 1 Apr 2016 | ₹223.40 | +291.9% |
| Highest weekly close since April 2016 · 14 Sep 2018 | ₹1,813.65 | −51.7% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹1,093.90 | −20.0% |
| 52-week low (weekly close) · 23 Oct 2026 | ₹836.75 | +4.6% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (557 weekly closes from 1 April 2016 to 4 November 2026.)

## What is the latest news on Excel Industries? 4 Nov 2026: Excel Industries closed at ₹875.40, up 3.5% on the week and down 5.0% on the month. 17 Sep 2026: ex-date for a dividend of ₹13.75 a share. ### Earlier

- Results for April to June 2026: Revenue down 5.2% and profit down 14.7% on a year earlier. - 25 May 2026: Excel Industries held its results call for January to March 2026. Management guided: Contract manufacturing dedicated production line expected operational by July 2026. ## What dividend does Excel Industries pay? Excel Industries paid ₹13.75 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.57% at the ₹875.40 close on 4 November 2026. The last was a dividend of ₹13.75 a share, ex-date 17 September 2026. ### Excel Industries dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 17 Sep 2026 | ₹13.75 | Dividend | same day |
| 14 Aug 2025 | ₹13.75 | Dividend | same day |
| 12 Sep 2024 | ₹5.50 | Dividend | same day |
| 7 Sep 2023 | ₹11.25 | Dividend | same day |
| 15 Sep 2022 | ₹22.50 | Dividend | 16 Sep 2022 |
| 16 Sep 2021 | ₹11.25 | Dividend | n/a |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Excel Industries Ltd paid out 23% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Excel Industries management say on the latest results call? On the call for January to March 2026, held on 25 May 2026, Excel Industries' management guided: Contract manufacturing dedicated production line expected operational by July 2026. > “The commissioning of our dedicated line to cater to the contract manufacturing agreement is on track and expected to be completed by July 2026”
> Ravi Shroff, on the call for January to March 2026

### What management guided

- Additional biocide product launch planned for H2 FY27; biocide characterization as fastest-growth product within performance solutions unconfirmed with no specific volume or margin guidance. - Capital spending ₹200-300 crore over 2-3 years with fixed asset turnover goal 1-1.5x and ROI goal 15-20%. - Near-term forward guidance withdrawn due to El Niño monsoon uncertainty and geopolitical raw material disruptions. - Anti-dumping investigations on HCDP and ATNP: preliminary findings expected September 2026 per normal investigation course. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/360/Conference Call/CC-May26.pdf). (From the call for January to March 2026, 25 May 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Excel Industries' next results? When Excel Industries reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Contract manufacturing dedicated production line expected operational July 2026 per roadmap; key catalyst to confirm as revenue starting point from multinational customer agreement. - What to check (from the call)
- Contract manufacturing dedicated production line expected operational July 2026 per roadmap; key catalyst to confirm as revenue starting point from multinational customer agreement. - HCDP and ATNP anti-dumping case preliminary findings expected September 2026; material outcome for agro intermediates pricing power and market share defense; magnitude of duty impact on margins still unknown. - El Niño monsoon forecast impact on April to June 2026 agro demand visibility; management withdrew forward guidance pending clarity, so next quarter will test whether suboptimal monsoon materialized and demand stayed pressured. - Raw material cost pass-through sustainability to customers; management successfully passed April-May increases but flagged uncertainty on permanence; next quarter pricing stickiness and customer resistance signal trend. ## Which stock lists is Excel Industries on? Excel Industries is on one of our India lists: Dividend stocks. [Dividend stocks Regular dividend yield (%): 1.57](https://www.sectoralpha.in/dividend-stocks-india)

## Is Excel Industries profitable? Excel Industries Ltd earned ₹29.0 Cr of net profit in the Jun 2026 quarter, −14.7% on the same quarter a year earlier. Full-year FY26 profit was ₹76.0 Cr. Over 10 years profit has grown 11.3% a year on average. That is 9.9% of the quarter's revenue. The same quarter a year earlier earned ₹34.0 Cr. For the full year, FY26 profit was ₹76.0 Cr (−10.6% on the year before). Why profit moved: revenue changed −5.2% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −5.8% and revenue +7.0%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Excel Industries make, and is it growing? Excel Industries Ltd reported ₹294 Cr of revenue in the Jun 2026 quarter, −5.2% on the same quarter a year earlier. Over 10 years it has grown 9.3% a year on average. The last full year, FY26, came in at ₹1,095 Cr. The last four reported quarters add to ₹1,079 Cr. FY26 revenue was ₹1,095 Cr, +12.0% on the year before. Recent pace: the last four quarters grew +7.0% on average, against 9.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +5.5%, against +10.9% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −20.5%, against +27.6% a year (rolling over). ## How much of every ₹100 of sales does Excel Industries keep? Excel Industries Ltd's operating margin was 14.0% in the Jun 2026 quarter, about the same as the same quarter a year ago. Across 13 years it has been between 3.0% and 30.0%. The latest quarter is within that range. In the latest quarter it moved +0.0 percentage points on the same quarter a year ago. Why the margin moved: operating margin changed +0.8 percentage points on the year while gross margin changed +4.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Excel Industries' profit turning into cash? Over the last 3 years, 105% of Excel Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹53.0 Cr of operating cash against ₹76.0 Cr of profit. After ₹79.0 Cr of spending on assets, free cash was −₹26.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 105% of profit came in as cash: the cash cycle got 45 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 1.7× depreciation over three years. The next section checks what that spending is building. ## Where does Excel Industries' cash go? Excel Industries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 74 days in FY26, up from 29 days in FY21. It spent ₹169 Cr on assets over the last 3 years. Customers take 87 days to pay, and stock sits for 81 days on average. At FY26 sales of ₹1,095 Cr, each day of that cycle ties up about ₹3.0 Cr, so roughly ₹222 Cr is tied up in the business at any time. FY26: customers took 87 days to pay and stock sat for 81 days, about 2.7 months of sales sitting as stock, for a full cycle of 74 days, longer than FY21's 29. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 81 days. Customers pay about 87 days after that. Suppliers are paid at 94 days. Together that makes the 74-day cycle. Spending on assets: ₹169 Cr over the last 3 years, against ₹102 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹38.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Excel Industries' P/E ratio, and how does it compare with its own history? Excel Industries Ltd's P/E is 15.4×, in the middle of its own history: higher than 39% of past readings. Its usual P/E (the middle reading) is 16.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −11.3% while the price moved −20.0%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −2.0% a year; about −3.3% a year came from earnings growth and about +1.3 percentage points from the multiple (the market paying more); over 10 years the price moved +7.2% a year; about +10.3% a year came from earnings growth and about −3.1 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Excel Industries business getting better or worse? Excel Industries Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −20.5% in the latest quarter, against +515.4% at its best in 12 quarters, with ROCE rising at 5.2%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Excel Industries earn on its capital? Excel Industries Ltd earned a ROCE of 6% in FY26. That is up from a low of 2% in FY24. Its return on capital used (ROIC) is 8.4 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 6.9% net margin and 0.52× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 6.9% net margin × 0.52× asset turnover × 1.24× leverage (assets divided by equity) ≈ 4.4% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 3.6% − 12.0% = −8.4 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Excel Industries have too much debt? Excel Industries Ltd has total debt of ₹8.0 Cr against shareholder equity of ₹1,703 Cr as of Jun 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.01 in FY22 to 0.00 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Excel Industries shareholding pattern? No group of Excel Industries Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.1 points over the same period, to 1.7%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −0.7 points over 8 quarters, to 51.9%; Foreign institutions: +0.1 points over 8 quarters, to 1.7%; Domestic institutions: +0.0 points over 8 quarters, to 7.0%. ## How far is Excel Industries from balance-sheet trouble? For Excel Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Excel Industries rank in its industry? 42.7 out of 100, rank 17 of 25 in Pesticides/Agrochemicals, with 64% of the evidence available. Excel Industries Ltd scores 42.7 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 17. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 12.8 + 9.6 + 10.4 + 9.9 = 42.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Excel Industries compared with? Excel Industries ranks 17 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 42.7 out of 100. 1. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.5/25 · ROCE 30.2% · Operating margin 16% · 100% evidence Valuation 19.2/20 · P/E 9.3× · PEG 0.3 · 100% evidence Relative strength 4.6/20 · Lead over its industry -14.3% · Lead over NIFTY 500 -22.1% · 1 year -23.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.5 + 19.5 + 19.2 + 4.6 = 71.8 · What this means: Earnings are strong; relative strength in its sector is -14.3% and the one-year return is -23.1%. 2. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) turning · Most evidence points up · 83% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.1/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 2 points · 83% evidence Capital efficiency 20.2/25 · ROCE 22.8% · Operating margin 21% · 95% evidence Valuation 5.4/20 · P/E 51.8× · PEG n/a · 50% evidence Relative strength 16.7/20 · Lead over its industry 38.3% · Lead over NIFTY 500 25.1% · 1 year 101.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.1 + 20.2 + 5.4 + 16.7 = 70.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · losing its lead · Most evidence points up · 81% evidence 65.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 8.7% · Profit 13.2% · Operating margin change 1 points · 88% evidence Capital efficiency 16.5/25 · ROCE 16.8% · Operating margin 15% · 100% evidence Valuation 17.5/20 · P/E 14.3× · PEG 0.38 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 4.7% · 1 year -9.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 16.5 + 17.5 + 12.2 = 65 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue -2.8% · Profit 23.8% · Operating margin change 2 points · 88% evidence Capital efficiency 19.7/25 · ROCE 29.1% · Operating margin 20% · 100% evidence Valuation 13.4/20 · P/E 20× · PEG 1.28 · 100% evidence Relative strength 8.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -20.8% · 1 year -33.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 19.7 + 13.4 + 8.6 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 81% evidence 63.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 8.2% · Profit 43.5% · Operating margin change 1 points · 88% evidence Capital efficiency 13.7/25 · ROCE 18.6% · Operating margin 12% · 100% evidence Valuation 15.9/20 · P/E 17.4× · PEG 0.33 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.4% · 1 year -36.4% · 25% evidence · 6 of 12 weeks ahead Exact sum: 24.3 + 13.7 + 15.9 + 9.8 = 63.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ADVANCE · breaking out · Evidence leans up · 64% evidence 58.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 48.4% · Profit 81.5% · Operating margin change 1 points · 88% evidence Capital efficiency 14.0/25 · ROCE 19.6% · Operating margin 11% · 100% evidence Valuation 10.3/20 · P/E 16.3× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 10.6% · 1 year -8.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 22.1 + 14 + 10.3 + 12.4 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans up · 81% evidence 57.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 17% · Profit 10.1% · Operating margin change -2 points · 88% evidence Capital efficiency 13.9/25 · ROCE 16.6% · Operating margin 14% · 100% evidence Valuation 18.2/20 · P/E 12× · PEG 0.36 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -23% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 13.9 + 18.2 + 8.2 = 57.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · turning · Evidence leans up · 100% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.8/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.7/25 · ROCE 25.9% · Operating margin 23% · 100% evidence Valuation 9.2/20 · P/E 14.4× · PEG 2.27 · 100% evidence Relative strength 17.4/20 · Lead over its industry 7.1% · Lead over NIFTY 500 -2.8% · 1 year -28.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10.8 + 19.7 + 9.2 + 17.4 = 57.1 · What this means: Relative strength against the index is -2.8%, and revenue and profit growth are weak. 9. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Evidence leans up · 93% evidence 54.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.4/25 · ROCE 11.4% · Operating margin 15% · 100% evidence Valuation 6.7/20 · P/E 24.7× · PEG 2.26 · 65% evidence Relative strength 8.4/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -11.7% · 1 year -19.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26 + 13.4 + 6.7 + 8.4 = 54.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) MOL · breaking out · Evidence leans up · 64% evidence 51.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue -7.8% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 9.3/25 · ROCE 6.7% · Operating margin 18% · 100% evidence Valuation 9.6/20 · P/E 20.8× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.5% · 1 year -35% · 25% evidence · 11 of 12 weeks ahead Exact sum: 22 + 9.3 + 9.6 + 11 = 51.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Too little evidence to rank firmly · 59% evidence 51.0 out of 100 Growth Capital Valuation Relative
12. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 81% evidence 49.5 out of 100 Growth Capital Valuation Relative
13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 48.4 out of 100 Growth Capital Valuation Relative
14. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · quiet · Evidence leans down · 96% evidence 45.3 out of 100 Growth Capital Valuation Relative
15. [Bhagiradha Chemicals & Industries Ltd](https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd) BHAGCHEM · quiet · Evidence leans down · 96% evidence 44.8 out of 100 Growth Capital Valuation Relative
16. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) SHIVALIK · Evidence leans down · 63% evidence 43.9 out of 100 Growth Capital Valuation Relative
17. Excel Industries Ltd this page EXCELINDUS · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 5.5% · Profit -20.4% · Operating margin change 0 points · 88% evidence Capital efficiency 9.6/25 · ROCE 6.2% · Operating margin 14% · 100% evidence Valuation 10.4/20 · P/E 15× · PEG n/a · 15% evidence Relative strength 9.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -6.1% · 1 year -24.5% · 25% evidence · 8 of 12 weeks ahead Exact sum: 12.8 + 9.6 + 10.4 + 9.9 = 42.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 18. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Evidence leans down · 96% evidence 42.0 out of 100 Growth Capital Valuation Relative
19. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans down · 90% evidence 41.9 out of 100 Growth Capital Valuation Relative
20. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 41.8 out of 100 Growth Capital Valuation Relative
21. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 71% evidence 41.5 out of 100 Growth Capital Valuation Relative
22. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 96% evidence 40.5 out of 100 Growth Capital Valuation Relative
23. [P I Industries Ltd](https://www.sectoralpha.in/stocks/p-i-industries-ltd) PIIND · quiet · Evidence leans down · 81% evidence 38.3 out of 100 Growth Capital Valuation Relative
24. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
25. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 76% evidence 29.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to Excel Industries in size? Excel Industries is the 20th largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: India Pesticides, Astec Lifesciences and Punjab Chemicals & Crop Protection. Just below it: Dharmaj Crop Guard, Advance Agrolife and Heranba Industries. ### Pesticides/Agrochemicals companies close in size

1. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) ₹1,297 crore
2. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ₹1,216 crore
3. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) ₹1,166 crore
4. Excel Industries Ltd ₹1,074 crore
5. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) ₹862 crore
6. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ₹797 crore
7. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) ₹580 crore

[All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies)

### Companies close in size in other industries

1. [BN Agrochem Ltd](https://www.sectoralpha.in/stocks/bn-agrochem-ltd) ₹1,076 crore · Trading
2. [Yatra Online Ltd](https://www.sectoralpha.in/stocks/yatra-online-ltd) ₹1,076 crore · E-Commerce - Platform - Travel
3. Excel Industries Ltd ₹1,074 crore
4. [Pradeep Metals Ltd](https://www.sectoralpha.in/stocks/pradeep-metals-ltd) ₹1,071 crore · Forgings
5. [Rhetan TMT Ltd](https://www.sectoralpha.in/stocks/rhetan-tmt-ltd) ₹1,068 crore · Steel Products

## What else do people ask about Excel Industries? ### What is Excel Industries's share price today? Excel Industries Ltd's share price is ₹875.40, −20.0% over the past year. The whole company is worth ₹1,101 Cr on the market. In the last 52 weeks it traded between ₹837 to ₹1,094; today it is 15% of the way up from the low, 9.6% below its 200-day average (as of 4 November 2026). ### What were Excel Industries's latest quarterly results? Excel Industries Ltd reported revenue of ₹294 Cr and net profit of ₹29.0 Cr for the Jun 2026 quarter. Revenue fell 5.2% and profit fell 14.7% compared with a year earlier. Earnings per share were ₹23.44. The operating margin was 14.0%, 0.0 percentage points higher than a year earlier (as of 4 November 2026). ### What is Excel Industries's market cap? Excel Industries Ltd's market capitalisation is ₹1,101 Cr at a share price of ₹875.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Excel Industries performing? Excel Industries Ltd's share price has been falling for 2 weeks. In its latest quarter, revenue fell 5.2% and profit fell 14.7% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 3 weeks running (as of 4 November 2026). ### Will Excel Industries's share price go up? This page does not forecast Excel Industries Ltd's share price. What it shows instead: the share price is ₹875.40, and it has been falling for 2 weeks. Its P/E of 15.4× is higher than 39% of its own last 11 years (as of 4 November 2026). ### Who owns Excel Industries? Promoters own 51.9% of Excel Industries Ltd, foreign institutions 1.7%, domestic institutions 7.0% and the public 39.5% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 4 November 2026). ### Where is Excel Industries in its business cycle? Excel Industries Ltd's FY26 operating margin was 10.0%, against a 13-year range of 3.0% to 30.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 14.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Excel Industries story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Excel Industries a stock worth studying right now? What the numbers show: Excel Industries Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Excel Industries share price forecast for 2026? What management itself guided: Contract manufacturing dedicated production line expected operational by July 2026. ## Lists

- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india

This is research, not advice. We’re not SEBI-registered.